US 9566294
Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
granted A61KA61K2039/505A61K31/713
Quick answer
US patent 9566294 (Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis) held by Northwest Biotherapeutics, Inc. expires Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Northwest Biotherapeutics, Inc.
- Grant date
- Tue Feb 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K2039/505, A61K31/713, A61K38/00, A61K45/06